Q: Can you comment on this fertility company and it’s recent earnings? Insider buying and ownership? Revenues and earnings are increasing, very little debt as far as can see? Why is the stock down for the past 5 years? I’m assuming the demand for fertility is increasing as we move forward (CAGR?)
Seems like s great opportunity to buy, but I’ll look forward to your opinion as always and it’s future prospects. What’s not to like?
Seems like s great opportunity to buy, but I’ll look forward to your opinion as always and it’s future prospects. What’s not to like?
Q: Do you see the recent dip in PGNY as an opportunity or did the recent results indicate something worrying? Do you agree with the assessment that there could be long-term, above-average growth possibilities and PGNY is emerging as a leader rather than just simply another OK investment?
Q: I'm reviewing my portfolio to evaluate if there are any names i've held for a few years which haven't done much or i'm down on, and may be candidates to be sold and replaced with growthier names that have become more attractive. The 2 names that meet the criteria are VEEV and PGNY. With a focus on growth do you think either of these names should be sold and replaced or are they holds? Thx